Wearable diagnostics are poised to transform subjective, episodic measures of disease progression to quantified, continuous data streams, according to some industry experts.
18 in after-market trading. Shares of Incyte have risen 5.4% year to date against the industry’s 11.1% decline. Incyte announced that it will pause enrollment in the ongoing phase II study of MRGPRX2 ...
Fifteen projects designed to reduce the growing global threat of antifungal drug resistance in low- and middle-income countries (LMICs) have received UK government funding via the University of Exeter ...